B. Kfir

Cytokine gene polymorphisms in patch-stage mycosis fungoides.

L. Akerman, A. Tambur, E. Hodak, 2005, Acta dermato-venereologica.

Cytokine gene polymorphisms in patch-stage mycosis fungoides1

L. Akerman, E. Hodak, M. David, 2004 .

Mycosis fungoides: HLA class II associations among Ashkenazi and non‐Ashkenazi Jewish patients

M. Lapidoth, C. Brautbar, E. Hodak, 2001, The British journal of dermatology.

Role of circulating soluble CD40 as an apoptotic marker in liver disease

O. Pappo, J. Sulkes, T. Klein, 2004, Apoptosis.

Circulating soluble cytochrome c in liver disease as a marker of apoptosis

O. Pappo, J. Sulkes, T. Klein, 2003, Journal of internal medicine.

Cytokine Gene Polymorphisms in Patients Infected With Hepatitis B Virus

Tirza Klein, J. Sulkes, A. Tambur, 2003, American Journal of Gastroenterology.

Cytokine gene polymorphism in patients with graft-versus-host disease.

I. Yaniv, T. Klein, A. Tambur, 2001, Transplantation proceedings.

CORRELATION BETWEEN TUMOUR AND SERUM β2m EXPRESSION IN PATIENTS WITH BREAST CANCER

J. Schachter, B. Kfir, R. Gal, 1996, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.

M. Mishaeli, B. Kfir, B. Klein, 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Rapid detection of toxicity in water using the oxygen uptake rate of mammalian cells as sensor

Bateman, R. Slabbert, B. Kfir, 1984 .

Initial TPS serum level as an indicator of relapse and survival in colorectal cancer.

J. Schachter, M. Mishaeli, I. Bayer, 1998, Anticancer research.

Soluble C-erbb-2 (p185) in breast-cancer patients in relation to prognosis.

M. Mishaeli, E. Rakowski, R. Weil, 1995, Oncology reports.